Barclays PLC Rallybio Corp Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Rallybio Corp stock. As of the latest transaction made, Barclays PLC holds 15,390 shares of RLYB stock, worth $10,157. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,390
Previous 15,390
-0.0%
Holding current value
$10,157
Previous $18,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RLYB
# of Institutions
50Shares Held
32.9MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$2.77 Million0.01% of portfolio
-
Johnson & Johnson New Brunswick, NJ3.64MShares$2.4 Million1.19% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$2.4 Million1.55% of portfolio
-
New Leaf Venture Partners, L.L.C. New York, NY3.3MShares$2.18 Million4.27% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$2 Million0.08% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $21.2M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...